Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
ENDO PHARMACEUTICLS (NQ: ENDP)
+0.00 (0.00%)
at
19.63
1,181,269 in Volume
Add to:
My Watchlist
Data as of 08:10 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 19.72
Bid (Size) 19.63 (3400)
Ask (Size) 20.60 (100)
Prev. Close 19.63
Today's Range 19.35 - 19.75
52wk Range 15.75 - 24.10
Shares Outstanding 117,259,235
Morningstar Profile
View Full Profile
ENDO PHARMACEUTICLS
A specialty pharmaceutical company, which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain.
Healthcare
Drug Manufacturers - Other
Exchange Traded NQ
Market Cap 2.30B
Related Companies BVF PALG BVF EKTAF
Featured News
Read More
Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone
Jan 27, 2010
from PRNewsWire News Releases
Endo Pharmaceuticals Announces Receipt of Paragraph IV Certification
Jan 19, 2010
from PRNewsWire News Releases
Featured News
Read More
Endo to Present at J.P. Morgan 28th Annual Healthcare Conference
Dec 30, 2009
from PRNewsWire News Releases
Endo Pharmaceuticals Provides Regulatory Update on AVEED(TM) (Testosterone Undecanoate) Injection
Dec 03, 2009
from PRNewsWire News Releases
Endo Pharmaceuticals and LecTec Settle Patent Dispute
Nov 11, 2009
from PRNewsWire News Releases
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Oct 29, 2009
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA